STAT Summit 2024 | STAT | 16 October 2024 | State Room: A Longwood Venue, 60 State St 33rd floor, Boston, MA 02109, United States

It doesn’t take a rocket scientist to see that getting new health technologies to market is incredibly hard, with companies in biotech and health tech falling apart as the funding environment worsens. By gathering real operators from the trenches who have not previously spoken out, not just talking heads, we’ll cover some of the biggest challenges faced by those who want to move advances out of the lab and into the world.

We’ll discuss everything from drug development and technology invention to dealing with regulators, courting investors, and pricing and selling products.

Why Attend:

• Cross industry audience
Top voices from the lab to the C-suite come together, alongside policymakers, patient advocates, and more

• Impactful live journalism
Our award-winning journalism brought to life by STAT’s editorial team, on stage and reporting directly from the summit floor

• Innovative speakers
Industry-shaping leaders take the stage for thought-provoking conversations, with live audience questions and discussion

2024 Speakers

George Addona, Ph.D.
Senior Vice President and Head, Discovery, Preclinical Development and Translational Medicine, Merck

Aaron Baugh, M.D.
Assistant Professor of Medicine, University of California San Francisco

Susan Baumgaertel, M.D.
Founder, myMDadvocate; Author, The Menopause Menu

Jay Bradner, M.D.
Executive Vice President, Research and Development, and Chief Scientific Officer, Amgen

Sherown Campbell
Advocate, Spinal Cord Injury Research and Rehabilitation

Tony Coles, M.D.
Chairman, Cerevel Therapeutics

Anjee Davis, MPPA
President, Fight Colorectal Cancer

Jazmin Evans
Kidney Transplant Survivor; Advocate for Equity in Healthcare and Solid Organ Transplant Systems

Atul Gawande, M.D.
Assistant Administrator of Global Health, United States of America International Development

Barney S. Graham, M.D., Ph.D.
Professor of Medicine and Microbiology, Biochemistry, and Immunology; Director of the David Satcher Global Health Equity Institute, Morehouse School of Medicine

Yvonne Greenstreet
CEO, Alnylam Pharmaceuticals

Jane Grogan, Ph.D.
Executive Vice President and Head of Research, Biogen

Robert I. Grossman, M.D.
Chief Executive Officer, NYU Langone Health; Dean, NYU Grossman School of Medicine

Dave Marver
CEO, Onward Medical

Fola May, M.D., Ph.D., MPhil
Associate Professor of Medicine, University of California Los Angeles (UCLA); Director of Quality Improvement, The Vatche and Tamar Manoukian Division of Digestive Diseases; Director, May Laboratory; Associate Director, UCLA Kaiser Permanente Center for Health Equity; Staff Physician, Veterans Affairs

Arif Nathoo, M.D.
CEO and Co-Founder, Komodo Health

Sunil A. Patel
Senior Vice President, Head of Corporate Development and Business Development & Licensing, Merck

Zachary J. Roberts, M.D., Ph.D.
Executive Vice President, Research & Development, Chief Medical Officer, Allogene Therapeutics

Marcel van den Brink, M.D., Ph.D.
President, City of Hope Los Angeles and City of Hope National Medical Center; Chief Physician Executive and The Deana and Steve Campbell Chief Physician Executive Distinguished Chair

Sonia Vallabh, Ph.D.
Senior Group Leader, Broad Institute; Assistant Professor of Neurology, Massachusetts General Hospital

D.A. Wallach
Venture Capital Investor and Recording Artist

Daphne Zohar
Founder, CEO, and Board Member of Seaport Therapeutics

Helen Branswell
Senior Writer, Infectious Diseases, STAT

Adam Feuerstein
Senior Writer, Biotech, STAT

Matthew Herper
Senior Writer, Medicine; Editorial Director of Events, STAT

Lizzy Lawrence
Medical Devices Reporter, STAT

Jason Mast
General Assignment Reporter, STAT

Usha Lee McFarling
National Science Correspondent, STAT

Sarah Owermohle
Washington Correspondent, STAT

Casey Ross
National Technology Correspondent, STAT

Nicholas St. Fleur
General Assignment Reporter; Associate Editorial Director of Events, STAT

2024 Sponsors

Presenting Sponsor:
• Merck

STAT Wunderkinds Sponsor:
• MD Anderson Cancer Center

Premium Sponsors:
• Allogene
• Boehringer Ingelheim
• City of Hope
• Fight
• Genentech
• Genmab
• NYU Langone Health

Supporting Sponsor:
• Doximity